The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy

BACKGROUND: There might be differential sensitivity to neoadjuvant chemotherapy (NAC) in patients with primary muscle-invasive bladder cancer (MIBC) in comparison to patients with secondary MIBC after a history of non–muscle-invasive disease. OBJECTIVE: To investigate pathologic response rates and s...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Andrea, David, Shariat, Shahrokh F., Soria, Francesco, Mari, Andrea, Mertens, Laura S., Di Trapani, Ettore, Carrion, Diego M., Pradere, Benjamin, Pichler, Renate, Filippot, Ronan, Grisay, Guillaume, Del Giudice, Francesco, Laukhtina, Ekaterina, Paulnsteiner, David, Krajewski, Wojciech, Vallet, Sonia, Maggi, Martina, De Berardinis, Ettore, Álvarez-Maestro, Mario, Brönimann, Stephan, Di Maida, Fabrizio, van Rhijn, Bas W.G., Hendricksen, Kees, Moschini, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Urothelial Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257642/
https://www.ncbi.nlm.nih.gov/pubmed/35813257
http://dx.doi.org/10.1016/j.euros.2022.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257642/
https://www.ncbi.nlm.nih.gov/pubmed/35813257
http://dx.doi.org/10.1016/j.euros.2022.05.001

Ejemplares similares